A new model to enhance enrollment of diverse participants to therapeutic clinical trials. A phase IV study of ApricityCARE program for cancer adverse events rapid evaluation to improve treatment ...
A Review of the Management of Hepatocellular Carcinoma: Standard Therapy and a Look to New Targets Single-agent management of metastatic biliary tract cancers with 5-fluorouracil (5-FU) or gemcitabine ...
If you or a loved one has gallbladder or bile duct cancer, you may be interested in learning more about treatments for it. For a long time, the standard treatment options for this cancer type were ...
Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results